A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of

See also
Status	Clinical Trial	Phase
Terminated	`NCT00251433` - GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer	Phase 1
Completed	`NCT01271738` - Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer	N/A
Recruiting	`NCT04892342` - Study of ESG401 in Adults With Solid Tumors	Phase 1/Phase 2
Terminated	`NCT02213042` - Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer	Phase 2
Withdrawn	`NCT01137994` - A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer	Phase 2
Completed	`NCT00790816` - Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents	Phase 1
Completed	`NCT00051103` - Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.	Phase 2
Completed	`NCT00320411` - GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer	Phase 2
Completed	`NCT00258050` - To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients	Phase 1
Terminated	`NCT01498588` - Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer	Phase 2
Terminated	`NCT00479856` - Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer	Phase 2
Completed	`NCT00320385` - Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer	Phase 3
Completed	`NCT00062686` - GW572016 For Treatment Of Refractory Metastatic Breast Cancer	Phase 2
Completed	`NCT00996762` - A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib	Phase 1
Terminated	`NCT02913729` - Pre- Versus Postoperative Accelerated Partial Breast Irradiation	N/A
Completed	`NCT01160211` - A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer	Phase 3
Recruiting	`NCT05814224` - Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA	N/A
Completed	`NCT01815294` - A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer	Phase 1
Terminated	`NCT00437073` - Brain Metastases In ErbB2-Positive Breast Cancer	Phase 2
Completed	`NCT00356811` - Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer	Phase 2

NCT number	NCT00849329
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 1
Start date	March 10, 2009
Completion date	November 24, 2009

A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms